Avance Clinical

Thebarton, Australia Founded: 2018 • Age: 8 yrs
Clinical development services are provided to pharmaceutical clients worldwide.

About Avance Clinical

Avance Clinical is a Healthcare company based in Thebarton (Australia) founded in 2018. Clinical development services are provided to pharmaceutical clients worldwide. Avance Clinical has completed 2 acquisitions, including C3 Research Associates and LumaBridge. Its chief executive, as recorded, is Yvonne Lungershausen. Its website avancecro.com draws about 20 thousand monthly visits. Its Indian entity Avance Clinical India Private Limited reported revenue of ₹9.35 Cr. Avance Clinical offers products and services including Clinical Operations, Data Management, Biostatistics, and Patient Recruitment. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Early Stage.

Company details

Avance Clinical was founded in 2018 and is headquartered in Thebarton, Australia. Operations focus on the contract research organization sector, where clinical development services are delivered to support pharmaceutical and biotechnology firms. These services encompass trial management, regulatory compliance, and data analysis, with activities spanning multiple therapeutic areas. Leadership is provided by CEO Yvonne Lungershausen, ensuring oversight of global projects.

  • Headquarters Thebarton, Australia
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website avancecro.com
  • Social LinkedIn X
  • Legal Name Avance Clinical India Private Limited
  • Date of Incorporation 28 Oct, 2022
  • Jurisdiction Bangalore, Karnataka, India
Key Metrics
  • Indian entity revenue
    ₹9.35 Cr

    FY 2025 · +199% YoY

  • Indian entity net profit
    ₹75.3 Lakh

    FY 2025 · 8% margin

  • Indian entity EBITDA
    ₹1.04 Cr

    FY 2025 · 11% margin

  • Investors
  • Investments & Acquisitions

Products & Services of Avance Clinical

Avance Clinical offers a comprehensive portfolio of products and services, including Clinical Operations, Data Management, Biostatistics, and Patient Recruitment.

Clinical Operations
Service

Manages clinical trial processes for biotechs

Data Management
Service

Handles data collection and analysis in trials

Biostatistics
Service

Provides statistical analysis for clinical studies

Patient Recruitment
Service

Facilitates participant enrollment in trials

Funding Insights of Avance Clinical

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Avance Clinical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2021Private Equity Round–Riverside
–
Valuation history

1 investors in total: 1 institutional.

Investors in Avance Clinical

Avance Clinical has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include The Riverside Company.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity and debt are provided to middle market companies.
riversidecompany.comCleveland, United States
Premium access

Investor details for Avance Clinical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Avance Clinical India Private Limited (Avance Clinical)

Avance Clinical India Private Limited is the primary company behind Avance Clinical. The board of Avance Clinical India Private Limited currently have 3 directors; the longest-serving is Gregory Charles Vella, appointed in 2022. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Gregory Charles Vella
DIN 09776284
Director28 Oct 20224 yrsAvance Clinical India Private Limited
Yadehalli Gundurao Ramya
DIN 10330968
Director22 Sep 20233 yrs 2 moAvance Clinical India Private Limited
Mark Landon Harvill
DIN 11219851
Additional Director30 Jul 20251 yr 3 moAvance Clinical India Private Limited

People of Avance Clinical

8 people are tracked at Avance Clinical (1 in leadership, 7 in board & advisors).

NameRoleGroup
CEOLeadership
Stuart Baxter
Board MemberBoard & advisors
Herman Scholtz
DirectorBoard & advisors
Daniel Spasic
Board MemberBoard & advisors
Kevin Xu
Board MemberBoard & advisors
Glenn Haifer
ChairmanBoard & advisors
Caroline Popper
DirectorBoard & advisors
Alek Safarian
Board MemberBoard & advisors
Premium access

Complete people profiles for Avance Clinical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Avance Clinical

Figures of Avance Clinical India Private Limited, the primary company behind Avance Clinical, for FY 2025. Revenue was ₹9.35 Cr (+199% year on year). Net profit was ₹75.3 Lakh (8% margin). EBITDA was ₹1.04 Cr (11% margin).

  • ₹9.35 CrRevenue · FY 2025 · +199% YoY
  • ₹75.3 LakhNet profit · 8% margin
  • ₹1.04 CrEBITDA · 11% margin
  • ₹50,000Paid-up capital
  • 18Employees (provident fund records)

Balance sheet, profit and loss, cash flow and ratios of Avance Clinical India Private Limited are on its company page.

Premium access

Detailed financial statements for Avance Clinical

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Avance Clinical

Avance Clinical has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include C3 Research Associates and LumaBridge.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Provider of oncology clinical research, regulatory affairs, and data management services
lumabridge.comSan Antonio, United States2000Jan 2026••••
CRO specializing in adaptive clinical trials
c3-research.comSeattle, United States2008Sep 2022••••
Premium access

Complete acquisition details for Avance Clinical

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Avance Clinical

4 dated milestones of Avance Clinical across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Avance Clinical is founded.
  2. Funding First funding round.
  3. Acquisition Acquires C3 Research Associates.
  4. Acquisition Acquires LumaBridge.

Web traffic of Avance Clinical

The website of Avance Clinical (avancecro.com) receives about 19.6K visits a month.

  • Monthly visits
    19.6K

    ▲ 39.3% vs previous month

Similar websites

Websites whose visitors overlap most with Avance Clinical. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
victrials.com.au
victrials.com.au
100%
#4,799,626–
accelagen.com.au
accelagen.com.au
95%
–
paratusclinical.com
93%
12.7K#1,515,022View details
momentumclinicalresearch.com.au
momentumclinicalresearch.com.au
91%
#1,089,398–
roche-australia.com
78%
680.7K#4,116,011View details
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 6 similar websites and full traffic analytics for Avance Clinical

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Avance Clinical

Premium access

Complete news archive for Avance Clinical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avance Clinical

Avance Clinical was founded in 2018 and raised its 1st funding round 3 years after it was founded.

Avance Clinical is headquartered in Thebarton, Australia. It is registered at Thebarton, South Australia, Australia.

Yvonne Lungershausen is the CEO of Avance Clinical, as recorded in our data.

The primary company behind Avance Clinical, Avance Clinical India Private Limited, reported revenue of ₹9.35 Cr for FY 2025, up 199% year on year.

Avance Clinical was founded in 2018 and is headquartered in Thebarton, Australia. Operations focus on the contract research organization sector, where clinical development services are delivered to support pharmaceutical and biotechnology firms. These services encompass trial management, regulatory compliance, and data analysis, with activities spanning multiple therapeutic areas. Leadership is provided by CEO Yvonne Lungershausen, ensuring oversight of global projects.

Avance Clinical offers Clinical Operations, Data Management, Biostatistics, and Patient Recruitment.

Avance Clinical has made 2 acquisitions, including C3 Research Associates, and LumaBridge.

Avance Clinical has 1 investor. Key investors include The Riverside Company.

Avance Clinical operates through Avance Clinical India Private Limited.

The legal entities of Avance Clinical currently have 3 directors, including Yadehalli Gundurao Ramya, Gregory Charles Vella, Mark Landon Harvill.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available